SMO Inhibition Modulates Cellular Plasticity and Invasiveness in Colorectal Cancer

Show full item record



Permalink

http://hdl.handle.net/10138/233478

Citation

Magistri , P , Battistelli , C , Strippoli , R , Petrucciani , N , Pellinen , T , Rossi , L , Mangogna , L , Aurello , P , D'Angelo , F , Tripodi , M , Ramacciato , G & Nigri , G 2018 , ' SMO Inhibition Modulates Cellular Plasticity and Invasiveness in Colorectal Cancer ' , Frontiers in Pharmacology , vol. 8 , 956 . https://doi.org/10.3389/fphar.2017.00956

Title: SMO Inhibition Modulates Cellular Plasticity and Invasiveness in Colorectal Cancer
Author: Magistri, Paolo; Battistelli, Cecilia; Strippoli, Raffaee; Petrucciani, Niccolo; Pellinen, Teijo; Rossi, Lucia; Mangogna, Livia; Aurello, Paolo; D'Angelo, Francesco; Tripodi, Marco; Ramacciato, Giovanni; Nigri, Giuseppe
Contributor organization: Institute for Molecular Medicine Finland
Precision Systems Medicine
Date: 2018-02-02
Language: eng
Number of pages: 13
Belongs to series: Frontiers in Pharmacology
ISSN: 1663-9812
DOI: https://doi.org/10.3389/fphar.2017.00956
URI: http://hdl.handle.net/10138/233478
Abstract: Colon Cancer (CC) is the fourth most frequently diagnosed tumor and the second leading cause of death in the USA. Abnormalities of Hedgehog pathway have been demonstrated in several types of human cancers, however the role of Hedgehog (Hh) in CC remain controversial. In this study, we analyzed the association between increased mRNA expression of GLI1 and GLI2, two Hh target genes, and CC survival and recurrence by gene expression microarray from a cohort of 382 CC patients. We found that patients with increased expression of GLI1 showed a statistically significant reduction in survival. In order to demonstrate a causal role of Hh pathway activation in the pathogenesis of CC, we treated HCT 116, SW480 and SW620 CC cells lines with GDC-0449, a pharmacological inhibitor of Smoothened (SMO). Treatment with GDC-0449 markedly reduced expression of Hh target genes GLI1, PTCH1, HIP1, MUC5AC, thus indicating that this pathway is constitutively active in CC cell lines. Moreover, GDC-0449 partially reduced cell proliferation, which was associated with upregulation of p21 and downregulation of CycD1. Finally, treatment with the same drug reduced migration and three-dimensional invasion, which were associated with downregulation of Snail1, the EMT master gene, and with induction of the epithelial markers Cytokeratin-18 and E-cadherin. These results were confirmed by SMO genetic silencing. Notably, treatment with 5E1, a Sonic Hedgehog-specific mAb, markedly reduced the expression of Hedgehog target genes, as well as inhibited cell proliferation and mediated reversion toward an epithelial phenotype. This suggests the existence of a Hedgehog autocrine signaling loop affecting cell plasticity and fostering cell proliferation andmigration/invasion in CC cell lines. These discoveries encourage future investigations to better characterize the role of Hedgehog in cellular plasticity and invasion during the different steps of CC pathogenesis.
Subject: colon cancer
hedgehog pathway
SMO inhibition
EMT
cell plasticity
cell invasiveness
EPITHELIAL-MESENCHYMAL TRANSITION
HEDGEHOG SIGNALING PATHWAY
COLON-CANCER
TUMOR-GROWTH
STEM-CELLS
IN-VITRO
ACTIVATION
PROLIFERATION
MECHANISMS
CARCINOMA
3111 Biomedicine
Peer reviewed: Yes
Rights: cc_by
Usage restriction: openAccess
Self-archived version: publishedVersion


Files in this item

Total number of downloads: Loading...

Files Size Format View
fphar_08_00956.pdf 2.240Mb PDF View/Open

This item appears in the following Collection(s)

Show full item record